New combo treatment for PCOS aims to boost fertility and metabolic health

NCT ID NCT07403201

First seen Feb 11, 2026 · Last updated May 05, 2026 · Updated 10 times

Summary

This study tests whether adding DLBS3233 to the standard drug clomiphene citrate works better than clomiphene alone for women with Polycystic Ovary Syndrome (PCOS). The goal is to improve insulin resistance, help eggs mature, and regulate menstrual cycles. About 90 married women will take part, and the results will be measured after 3 months of treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • RS AMC Yogyakarta

    RECRUITING

    Yogyakarta, DIY, 55253, Indonesia

    Contact Phone: •••-•••-••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.